- Home
- SRPT vs NYT Comparison
SRPT vs NYT Comparison
Compare SRPT & NYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRPT
- NYT
- Stock Information
- Founded
- SRPT 1980
- NYT 1851
- Country
- SRPT United States
- NYT United States
- Employees
- SRPT N/A
- NYT N/A
- Industry
- SRPT Biotechnology: Pharmaceutical Preparations
- NYT Newspapers/Magazines
- Sector
- SRPT Health Care
- NYT Consumer Discretionary
- Exchange
- SRPT Nasdaq
- NYT Nasdaq
- Market Cap
- SRPT N/A
- NYT 8.6B
- IPO Year
- SRPT 1997
- NYT N/A
- Fundamental
- Price
- SRPT $36.52
- NYT $52.63
- Analyst Decision
- SRPT Buy
- NYT Buy
- Analyst Count
- SRPT 23
- NYT 6
- Target Price
- SRPT $131.09
- NYT $55.50
- AVG Volume (30 Days)
- SRPT 3.8M
- NYT 1.7M
- Earning Date
- SRPT 05-06-2025
- NYT 05-07-2025
- Dividend Yield
- SRPT N/A
- NYT 1.37%
- EPS Growth
- SRPT N/A
- NYT 21.26
- EPS
- SRPT N/A
- NYT 1.83
- Revenue
- SRPT $2,233,371,000.00
- NYT $2,600,814,000.00
- Revenue This Year
- SRPT $64.51
- NYT $8.41
- Revenue Next Year
- SRPT $22.40
- NYT $5.95
- P/E Ratio
- SRPT N/A
- NYT $28.76
- Revenue Growth
- SRPT 59.15
- NYT 6.90
- 52 Week Low
- SRPT $35.46
- NYT $44.83
- 52 Week High
- SRPT $173.25
- NYT $58.16
- Technical
- Relative Strength Index (RSI)
- SRPT 22.82
- NYT 68.72
- Support Level
- SRPT $59.62
- NYT $51.31
- Resistance Level
- SRPT $64.80
- NYT $53.35
- Average True Range (ATR)
- SRPT 3.75
- NYT 1.00
- MACD
- SRPT -1.21
- NYT 0.22
- Stochastic Oscillator
- SRPT 3.61
- NYT 85.09
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
About NYT New York Times Company (The)
New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company has two segments: New York Times Group and The Athletic. The company generates the majority of its revenue from the NYTG segment. The NYTG and The Athletic segments derive revenue from subscriptions, Advertising, and others, where the majority source of revenue for both segments is subscription.